1. Home
  2. MCHB vs BLLN Comparison

MCHB vs BLLN Comparison

Compare MCHB & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mechanics Bancorp

MCHB

Mechanics Bancorp

HOLD

Current Price

$14.91

Market Cap

3.8B

Sector

Finance

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$121.91

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHB
BLLN
Founded
1905
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.4B
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
MCHB
BLLN
Price
$14.91
$121.91
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$15.75
★ $126.71
AVG Volume (30 Days)
402.5K
★ 517.6K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
★ 5.53%
N/A
EPS Growth
★ 116.60
103.40
EPS
0.46
★ 0.48
Revenue
$49,728,000.00
★ $305,112,000.00
Revenue This Year
$43.32
$46.29
Revenue Next Year
N/A
$30.14
P/E Ratio
★ $33.01
$256.74
Revenue Growth
3.33
★ 99.97
52 Week Low
$12.82
$61.96
52 Week High
$17.38
$150.44

Technical Indicators

Market Signals
Indicator
MCHB
BLLN
Relative Strength Index (RSI) 32.21 64.44
Support Level $14.53 $113.30
Resistance Level $14.99 $150.44
Average True Range (ATR) 0.29 6.63
MACD -0.02 2.92
Stochastic Oscillator 6.51 81.06

Price Performance

Historical Comparison
MCHB
BLLN

About MCHB Mechanics Bancorp

Mechanics Bancorp is the financial holding company of Mechanics Bank, a full-service bank with branches across California, Oregon, Washington and Hawaii. It offers a various products and services in consumer and business banking, commercial lending, cash management services, private banking, and comprehensive wealth management and trust services.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: